Thursday, March 14, 2013

Empowered women: Female execs in pharmaceuticals

While the executive positions in most giant pharmaceutical companies are held by men, the number of women holding executive positions in the industry have grown in recent years. Below are three females making a name for themselves in the field of pharmaceuticals:


1. Beatrice Cazala, Executive Vice President (Commercialization Operations) of Bristol-Myers Squibb



Image Source: fiercepharma.com


Beatrice Cazala heads the development of the company’s BioPharma strategy through proactive innovation and the implementation of global external company policies across all regions. Having been with the company for 30 years, she joined BMS in 1982 as a product manager based in France.


2. Mary Szela, Senior Vice President of the Global Strategic Marketing and Services division of Abbott Laboratories



Image Source: businessinsider.com


Mary Szela has been with Abbott for more than 20 years, and prior to her current role, she held leadership positions in various divisions of the company, including SVP for U.S. Pharmaceuticals and SVP for Pharmaceutical Operations.


3. Sue Mahony, President of Lilly Oncology and Senior Vice President of Eli Lilly and Company




Image Source: ibj.com


She is formerly the company’s SVP of the Human Resources and Diversity division. She joined Lilly in 2000 after more than a decade of holding sales and marketing roles in oncology/hematology and cardiovascular medicine for Schering-Plough, Amgen, and Bristol-Myers Squibb.


These women execs have been in the pharma industry for quite a while, and are backed by a solid education background. They serve as inspiration to other females who want to pursue a career in pharmaceutical sciences to help cure and treat a wide variety of medical conditions.


This Mary Szela Twitter page shares updates on the latest in medicine.